Skip to main content
. 2008 Jun 2;52(8):2855–2860. doi: 10.1128/AAC.00014-08

FIG. 1.

FIG. 1.

Visual predictive check of population pharmacokinetic model for miltefosine. The open dots present data for all analyzed study samples (n = 382) from 31 Dutch military personnel with cutaneous leishmaniasis (L. major) contracted in Afghanistan. All patients were treated with 50 mg of oral miltefosine three times daily for a total of 28 days. The gray area shows the 90% confidence interval of the model predictions; the dashed line displays the median predicted concentrations.